463 related articles for article (PubMed ID: 10805352)
1. Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation.
Schultz DR; Diego JM
Semin Arthritis Rheum; 2000 Apr; 29(5):267-85. PubMed ID: 10805352
[TBL] [Abstract][Full Text] [Related]
2. Antineutrophil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations.
Schultz DR; Tozman EC
Semin Arthritis Rheum; 1995 Dec; 25(3):143-59. PubMed ID: 8650585
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
[TBL] [Abstract][Full Text] [Related]
4. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
[TBL] [Abstract][Full Text] [Related]
6. [New aspects in ANCA-associated vasculitides].
Lamprecht P
Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181
[TBL] [Abstract][Full Text] [Related]
7. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis.
Gross WL; Csernok E; Helmchen U
APMIS; 1995 Feb; 103(2):81-97. PubMed ID: 7748541
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
9. [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
Bosch X; Mirapeix E; Font J; López-Soto A; Rodríguez R; Vivancos J; Revert L; Ingelmo M; Urbano-Márquez A
Med Clin (Barc); 1994 Mar; 102(11):412-7. PubMed ID: 8182997
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.
Merkel PA; Polisson RP; Chang Y; Skates SJ; Niles JL
Ann Intern Med; 1997 Jun; 126(11):866-73. PubMed ID: 9163287
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcgamma receptor ligation.
Ben-Smith A; Dove SK; Martin A; Wakelam MJ; Savage CO
Blood; 2001 Sep; 98(5):1448-55. PubMed ID: 11520794
[TBL] [Abstract][Full Text] [Related]
12. p-ANCA with myeloperoxidase antibodies and c-ANCA with proteinase 3 antibodies define a different vasculitis entity in patients with renal involvement.
Dringenberg C; Apenberg S; Andrassy K
Adv Exp Med Biol; 1993; 336():445-7. PubMed ID: 8296653
[TBL] [Abstract][Full Text] [Related]
13. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
14. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
15. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
16. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
17. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis.
Fienberg R; Mark EJ; Goodman M; McCluskey RT; Niles JL
Hum Pathol; 1993 Feb; 24(2):160-8. PubMed ID: 8381764
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
[TBL] [Abstract][Full Text] [Related]
20. [New aspects of antineutrophil cytoplasmic antibody (ANCA) diagnosis in vasculitis].
Csernok E; Reichel P; Gross WL
Z Rheumatol; 2002 Aug; 61(4):367-77. PubMed ID: 12426842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
